Mitochondrial genetic diseases

Current Opinion in Pediatrics

Volumn 22, Issue 6, 2010, Pages 711-716

  Falk, Marni J ^a   Sondheimer, Neal ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

diagnosis; mtDNA; nDNA; respiratory chain; therapy

Indexed keywords

BUTIN; CYTOCHROME C OXIDASE; FLAVONOID; GLUCOSE; IDEBENONE; MITOCHONDRIAL DNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSFER RNA; TROLOX C; UBIDECARENONE; UNCLASSIFIED DRUG;

CLINICAL FEATURE; COENZYME Q10 DEFICIENCY; CYTOCHROME C OXIDASE DEFICIENCY; CYTOGENETICS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA SEQUENCE; GENE MUTATION; GENETIC ANALYSIS; HUMAN; INTESTINE OBSTRUCTION; KEARNS SAYRE SYNDROME; LEBER HEREDITARY OPTIC NEUROPATHY; LEIGH DISEASE; MELAS SYNDROME; MERRF SYNDROME; MITOCHONDRIAL DNA DEPLETION SYNDROME; MYOPATHY; NONHUMAN; NYSTAGMUS; OPHTHALMOPLEGIA; PATIENT CARE; PHOTOPHOBIA; PRIORITY JOURNAL; PTOSIS; REFRACTION ERROR; RETINA DYSTROPHY; REVIEW; STRABISMUS; VERTICAL TRANSMISSION; VISUAL ACUITY;

ANTIOXIDANTS; DNA, MITOCHONDRIAL; HUMANS; MITOCHONDRIAL DISEASES;

EID: 78649511577     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e3283402e21     Document Type: Review

References (32)

1. Gronlund MA, Honarvar AK, Andersson S, et al. Ophthalmological findings in children and young adults with genetically verified mitochondrial disease. Br J Ophthalmol 2010; 94:121-127.
2. Amiot A, Tchikviladze M, Joly F, et al. Frequency of mitochondrial defects in patients with chronic intestinal pseudo-obstruction. Gastroenterology 2009; 137:101-109.
3. Sacconi S, Trevisson E, Salviati L, et al. Coenzyme Q10 is frequently reduced in muscle of patients with mitochondrial myopathy. Neuromuscul Disord 2010; 20:44-48.
4. Bredenoord A, Dondorp W, Pennings G, et al. Preimplantation genetic diagnosis for mitochondrial DNA disorders: Ethical guidance for clinical practice. Eur J Hum Genet 2009; 17:1550-1559.
5. Bredenoord AL, Krumeich A, De Vries MC, et al. Reproductive decisionmaking in the context of mitochondrial DNA disorders: Views and experiences of professionals. Clin Genet 2010; 77:10-17.
6. Cree LM, Samuels DC, Chinnery PF. The inheritance of pathogenic mitochondrial DNA mutations. Biochim Biophys Acta 2009; 1792:1097-1102.
7. Craven L, Tuppen HA, Greggains GD, et al. Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease. Nature 2010; 465:82-85.
8. Tachibana M, Sparman M, Sritanaudomchai H, et al. Mitochondrial gene replacement in primate offspring and embryonic stem cells. Nature 2009; 461:367-372.
9. Horvath R, Kemp JP, Tuppen HA, et al. Molecular basis of infantile reversible cytochrome c oxidase deficiency myopathy. Brain 2009; 132:3165-3174.
10. Duncan AJ, Bitner-Glindzicz M, Meunier B, et al. A nonsense mutation in COQ9 causes autosomal-recessive neonatal-onset primary coenzyme Q10 deficiency: A potentially treatable form of mitochondrial disease. Am J Hum Genet 2009; 84:558-566.
11. Weraarpachai W, Antonicka H, Sasarman F, et al. Mutation in TACO1, encoding a translational activator of COX I, results in cytochrome c oxidase deficiency and late-onset Leigh syndrome. Nat Genet 2009; 41:833-837.
12. Saada A, Vogel RO, Hoefs SJ, et al. Mutations in NDUFAF3 (C3ORF60), encoding an NDUFAF4 (C6ORF66)-interacting complex I assembly protein, cause fatal neonatal mitochondrial disease. Am J Hum Genet 2009; 84:718-727.
13. Mayr JA, Havlickova V, Zimmermann F, et al. Mitochondrial ATP synthase deficiency due to a mutation in the ATP5E gene for the F1 epsilon subunit. Hum Mol Genet 2010; 19:3430-3439.
14. Janssen RJ, Distelmaier F, Smeets R, et al. Contiguous gene deletion of ELOVL7, ERCC8 and NDUFAF2 in a patient with a fatal multisystem disorder. Hum Mol Genet 2009; 18:3365-3374.
15. Dimmock D, Tang LY, Schmitt ES, Wong LJ. Quantitative evaluation of the mitochondrial DNA depletion syndrome. Clin Chem 2010; 56:1119-1127.
16. Almousa R, Charlton A, Rajesh ST, et al. Optimizing muscle biopsy for the diagnosis of mitochondrial myopathy. Ophthal Plast Reconstr Surg 2009; 25:366-370.
17. Wibrand F, Jeppesen TD, Frederiksen AL, et al. Limited diagnostic value of enzyme analysis in patients with mitochondrial tRNA mutations. Muscle Nerve 2010; 41:607-613.
18. Jonckheere AI, Huigsloot M, Janssen AJ, et al. High-throughput assay to measure oxygen consumption in digitonin-permeabilized cells of patients with mitochondrial disorders. Clin Chem 2010; 56:424-431.
19. Smet J, Seneca S, De Paepe B, et al. Subcomplexes of mitochondrial complex V reveal mutations in mitochondrial DNA. Electrophoresis 2009; 30:3565-3572.
20. Diogo L, Cordeiro M, Garcia P, et al. Value of brain magnetic resonance imaging in mitochondrial respiratory chain disorders. Pediatr Neurol 2010; 42:196-200.
21. Blackwood JK, Whittaker RG, Blakely EL, et al. The investigation and diagnosis of pathogenic mitochondrial DNA mutations in human urothelial cells. Biochem Biophys Res Commun 2010; 393:740-745.
22. Vasta V, Ng SB, Turner EH, et al. Next generation sequence analysis for mitochondrial disorders. Genome Med 2009; 1:100.
23. Acin-Perez R, Salazar E, Brosel S, et al. Modulation of mitochondrial protein phosphorylation by soluble adenylyl cyclase ameliorates cytochrome oxidase defects. EMBO Mol Med 2009; 1:392-406.
24. Coppola G, Marmolino D, Lu D, et al. Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia. Hum Mol Genet 2009; 18:2452-2461.
25. Vercauteren K, Gleyzer N, Scarpulla RC. Short hairpin RNA-mediated silencing of PRC (PGC-1-related coactivator) results in a severe respiratory chain deficiency associated with the proliferation of aberrant mitochondria. J Biol Chem 2009; 284:2307-2319.
26. Wenz T. PGC-1alpha activation as a therapeutic approach in mitochondrial disease. IUBMB Life 2009; 61:1051-1062.
27. Wenz T, Diaz F, Hernandez D, Moraes CT. Endurance exercise is protective for mice with mitochondrial myopathy. J Appl Physiol 2009; 106:1712-1719.
28. Atkuri KR, Cowan TM, Kwan T, et al. Inherited disorders affecting mitochondrial function are associated with glutathione deficiency and hypocitrullinemia. Proc Natl Acad Sci U S A 2009; 106:3941-3945.
29. Distelmaier F, Visch HJ, Smeitink JA, et al. The antioxidant Trolox restores mitochondrial membrane potential and Ca2+-stimulated ATP production in human complex I deficiency. J Mol Med 2009; 87:515-522.
30. Haginoya K, Miyabayashi S, Kikuchi M, et al. Efficacy of idebenone for respiratory failure in a patient with Leigh syndrome: A long-term follow-up study. J Neurol Sci 2009; 278:112-114.
31. Zhang R, Kang KA, Piao MJ, et al. Butin reduces oxidative stress-induced mitochondrial dysfunction via scavenging of reactive oxygen species. Food Chem Toxicol 2010; 48:922-927.
32. Parini R, Furlan F, Notarangelo L, et al. Glucose metabolism and diet-based prevention of liver dysfunction in MPV17 mutant patients. J Hepatol 2009; 50:215-221.